Mon, Jul 28, 2014, 12:00 PM EDT - U.S. Markets close in 4 hrs.


% | $
Click the to save as a favorite.

Gilead Sciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • pkornie Jan 20, 2012 7:43 AM Flag

    Dead cat bounce...suckers. Now I'm pissed

    << Message board name is either empty or non-existent >>.(___O___).

    << 1:31AM Gilead Sciences: FDA approves new formulations of Viread for use by children living with HIV (GILD) 46.26 : Co announces the FDA has approved Viread in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12. The FDA approved a supplemental New Drug Application for three lower-strength once-daily tablets of Viread in doses of 150 mg, 200 mg and 250 mg for children ages 6-12. The agency also approved a New Drug Application for an oral powder formulation of Viread for children ages 2-5. The pediatric regulatory applications for Viread were supported by clinical data from a Phase 3 safety and efficacy study of a Viread-containing antiretroviral regimen compared to an antiretroviral regimen containing zidovudine or stavudine in HIV-infected treatment-experienced children ages 2-12. The safety profile observed in the study was consistent with that observed in clinical trials in adults. The applications were submitted to the FDA on July 18, 2011.




    Sentiment : Strong Buy

91.18+1.34(+1.49%)12:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.